Dolutegravir and rilpivirine as successful initial antiretroviral therapy in a treatment-naive patient with HIV-1: A case report

Antivir Ther. 2023 Dec;28(6):13596535231218875. doi: 10.1177/13596535231218875.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • HIV Infections* / drug therapy
  • HIV Seropositivity*
  • HIV-1*
  • Humans
  • Rilpivirine / therapeutic use

Substances

  • Rilpivirine
  • dolutegravir